Summit Therapeutics
SMMT
#1549
Rank
โ‚น1.259 T
Marketcap
โ‚น1,625
Share price
-3.79%
Change (1 day)
-5.13%
Change (1 year)

Market capitalization of Summit Therapeutics (SMMT)

Market cap: โ‚น1.259 Trillion

As of March 2026 Summit Therapeutics has a market cap of โ‚น1.259 Trillion. This makes Summit Therapeutics the world's 1549th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Summit Therapeutics from 2015 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น1.259 T3.91%
2025โ‚น1.212 T5.23%
2024โ‚น1.152 T656.52%
2023โ‚น152.27 B115.08%
2022โ‚น70.80 B261.89%
2021โ‚น19.56 B-30.81%
2020โ‚น28.27 B268.89%
2019โ‚น7.66 B479.35%
2018โ‚น1.32 B-87.47%
2017โ‚น10.55 B47.62%
2016โ‚น7.15 B-23.64%
2015โ‚น9.36 B

End of Day market cap according to different sources

On Mar 26th, 2026 the market cap of Summit Therapeutics was reported to be:

โ‚น1.259 Trillion
by Nasdaq info icon info icon
โ‚น1.259 Trillion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sarepta Therapeutics
SRPT
โ‚น214.24 B-82.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
โ‚น21.05 B-98.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
โ‚น23.41 B-98.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
โ‚น580.29 B-53.93%๐Ÿ‡บ๐Ÿ‡ธ USA